 |
| |
| Apr-03-18 | Upgrade |
Raymond James |
Mkt Perform → Outperform |
|
|
| Jan-05-18 | Downgrade |
Craig Hallum |
Buy → Hold |
|
|
| Apr-07-17 | Reiterated |
Cantor Fitzgerald |
Overweight |
$20 → $21 |
|
| Mar-30-17 | Downgrade |
KeyBanc Capital Mkts |
Overweight → Sector Weight |
|
|
| Feb-08-17 | Initiated |
Barclays |
Equal Weight |
$17 |
|
| Nov-04-16 | Initiated |
Cantor Fitzgerald |
Buy |
|
|
| Apr-08-16 | Resumed |
Piper Jaffray |
Neutral |
|
|
| Jan-08-16 | Reiterated |
Canaccord Genuity |
Buy |
$17.50 → $14.50 |
|
| Nov-10-15 | Downgrade |
Raymond James |
Outperform → Mkt Perform |
|
|
| Jul-24-15 | Initiated |
KeyBanc Capital Mkts |
Overweight |
|
|
| Jun-19-14 | Upgrade |
Canaccord Genuity |
Hold → Buy |
$16.25 → $20 |
|
| Oct-09-12 | Reiterated |
Canaccord Genuity |
Hold |
$14 → $13.50 |
|
| Jun-25-12 | Downgrade |
Canaccord Genuity |
Buy → Hold |
$16.50 → $14.50 |
|
| Jul-15-11 | Upgrade |
Stifel Nicolaus |
Hold → Buy |
$16.50 |
|
| Jul-15-11 | Upgrade |
Canaccord Genuity |
Hold → Buy |
$15 → $16.50 |
|
| Jun-14-11 | Downgrade |
Wedbush |
Neutral → Underperform |
$14 → $12 |
|
| Sep-08-10 | Reiterated |
Wedbush |
Neutral |
$17.50 → $14 |
|
| Mar-04-10 | Initiated |
Wedbush Morgan |
Neutral |
$17.50 |
|
| Sep-04-09 | Reiterated |
Caris & Company |
Above Average |
$13 → $15 |
|
| Jul-17-09 | Reiterated |
Caris & Company |
Above Average |
$15 → $13 |
|
|
|
| Apr-10-18 04:01PM | AngioDynamics to Present at Two Investor Conferences in May Business Wire |
| Apr-05-18 07:20AM | Blog Exposure - Waters Corp. to Significantly Expand its Precision Chemistry Facility in Massachusetts ACCESSWIRE |
| Apr-04-18 08:20AM | Recent Analysis Shows Multi-Color, Madrigal Pharmaceuticals, SPX, AngioDynamics, Atara Biotherapeutics, and Quanex Building Products Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire |
| Apr-03-18 10:25AM | AngioDynamics (ANGO) Product Line Strong, Debt Level High Zacks +5.57% |
| Apr-02-18 10:15AM | AngioDynamics (ANGO) Beats on Q3 Earnings, Reiterates View Zacks |
| Apr-01-18 10:10AM | AngioDynamics (ANGO) Q3 2018 Earnings Conference Call Transcript Motley Fool |
| Mar-29-18 07:25PM | Edited Transcript of ANGO earnings conference call or presentation 29-Mar-18 12:00pm GMT Thomson Reuters StreetEvents |
| 07:59AM | Where AngioDynamics Inc (NASDAQ:ANGO) Stands In Earnings Growth Against Its Industry Simply Wall St. |
| 07:12AM | AngioDynamics misses 3Q revenue forecasts Associated Press |
| 07:00AM | AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results Business Wire |
| 06:00AM | AngioDynamics, Inc. to Host Earnings Call ACCESSWIRE |
| Mar-15-18 04:01PM | AngioDynamics to Present at the Needham 17th Annual Healthcare Conference Business Wire |
| Feb-27-18 04:01PM | AngioDynamics to Report Fiscal 2018 Third Quarter Financial Results on March 29, 2018 Business Wire |
| Feb-15-18 08:00AM | AngioDynamics to Present at the Barclays Global Healthcare Conference Business Wire |
| Feb-06-18 08:00AM | Investor Expectations to Drive Momentum within Regal Beloit, Kaiser Aluminum, AngioDynamics, Mulesoft, Assembly Biosciences, and Woodward Discovering Underlying Factors of Influence GlobeNewswire |
| Jan-26-18 10:56AM | AngioDynamics Receives FDA Nod, to Treat Pancreatic Cancer Zacks |
| Jan-25-18 07:30AM | Free Post Earnings Research Report: Waters Sales Jumped 9%; Adjusted EPS Surged 14% ACCESSWIRE |
| Jan-24-18 04:01PM | AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife® System for the Treatment of Stage III Pancreatic Cancer Business Wire |
| 07:59AM | AngioDynamics (ANGO) Banks on Buyouts, Debt Level High Zacks |
| Jan-19-18 10:55AM | AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q2, 2018 By the Numbers : January 19, 2018 Capital Cube |
| Jan-10-18 09:05AM | Zacks.com featured highlights include: AngioDynamics, Zumiez, GP Strategies, AngloGold and Raymond James Zacks |
| Jan-09-18 07:42AM | Bet on These 5 PEG-Ratio Based GARP Picks Zacks |
| Jan-05-18 03:30PM | AngioDynamics (ANGO) Misses on Earnings, Revenues in Q2 Zacks |
| Jan-04-18 08:45PM | Edited Transcript of ANGO earnings conference call or presentation 4-Jan-18 1:00pm GMT Thomson Reuters StreetEvents |
| 07:11AM | AngioDynamics misses Street 2Q forecasts Associated Press |
| 07:00AM | AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results Business Wire |
| Jan-03-18 01:37PM | Can AngioDynamics (ANGO) Pull a Surprise in Q2 Earnings? Zacks |
| Dec-28-17 11:48AM | ETFs with exposure to AngioDynamics, Inc. : December 28, 2017 Capital Cube |
| Dec-19-17 04:01PM | AngioDynamics to Present at the J.P. Morgan Healthcare Conference Business Wire |
| Dec-15-17 08:00AM | AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : December 15, 2017 Capital Cube |
| Dec-11-17 04:01PM | AngioDynamics to Report Fiscal 2018 Second Quarter Financial Results on January 4, 2018 Business Wire |
| Dec-05-17 07:47AM | AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : December 5, 2017 Capital Cube |
| Nov-24-17 11:12AM | AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : November 24, 2017 Capital Cube |
| Nov-22-17 07:30AM | AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : November 22, 2017 Capital Cube |
| Oct-30-17 04:11AM | Why Is AngioDynamics (ANGO) Up 5.3% Since the Last Earnings Report? Zacks |
| Oct-27-17 10:43AM | ETFs with exposure to AngioDynamics, Inc. : October 27, 2017 Capital Cube |
| Oct-17-17 08:05AM | AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : October 17, 2017 Capital Cube |
| Oct-11-17 07:40AM | Earnings Review and Free Research Report: AngioDynamics Reported Lower than Expected Quarterly Results ACCESSWIRE |
| Oct-04-17 10:31AM | ETFs with exposure to AngioDynamics, Inc. : October 4, 2017 Capital Cube |
| 08:51AM | AngioDynamicis' (ANGO) Solero MTA System to Drive Growth Zacks |
| 07:00AM | Earnings Review and Free Research Report: Lakelands Revenue Jumped 7.4%; EPS Surged 25% ACCESSWIRE |
| Oct-03-17 09:43AM | AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q1, 2018 By the Numbers : October 3, 2017 Capital Cube |
| 07:00AM | Corporate News Blog - Skyline Medical Provides Update on Pending CytoBioscience Merger ACCESSWIRE |
| Oct-02-17 11:14AM | AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : October 2, 2017 Capital Cube |
| 10:08AM | AngioDynamics (ANGO) Misses on Earnings & Revenues in Q1 Zacks |
| Sep-29-17 08:15AM | AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : September 29, 2017 Capital Cube |
| Sep-28-17 09:41PM | AngioDynamics misses Street 1Q forecasts Associated Press -13.17% |
| 06:00AM | AngioDynamics Reports Fiscal 2018 First Quarter Results GlobeNewswire |
| Sep-26-17 07:09AM | Can AngioDynamics (ANGO) Spring a Surprise in Q1 Earnings? Zacks |
| Sep-18-17 08:06AM | AngioDynamics' BioFlo Platform Strong, Debt Levels High Zacks |
| Sep-14-17 07:00AM | Outcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open GlobeNewswire |
| 06:00AM | AngioDynamics to Report Fiscal 2018 First Quarter Financial Results GlobeNewswire |
| Sep-13-17 06:00AM | AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire |
| Aug-29-17 06:00AM | AngioDynamics to Present at the 2017 Morgan Stanley Global Healthcare Conference GlobeNewswire |
| Aug-18-17 04:20PM | ETFs with exposure to AngioDynamics, Inc. : August 18, 2017 Capital Cube |
| 03:41AM | AngioDynamics (ANGO) Up 10.8% Since Earnings Report: Can It Continue? Zacks |
| Aug-12-17 11:40PM | Edited Transcript of ANGO earnings conference call or presentation 18-Jul-17 12:00pm GMT Thomson Reuters StreetEvents |
| Aug-08-17 09:52AM | AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q4, 2017 By the Numbers : August 8, 2017 Capital Cube |
| Aug-07-17 07:49AM | AngioDynamics to Present at the 2017 Canaccord Genuity Growth Conference GlobeNewswire |
| Jul-27-17 04:25PM | IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire |
| Jul-26-17 09:19AM | INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of AngioDynamics, Inc. - ANGO PR Newswire |
| Jul-24-17 06:56PM | INVESTOR ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire +7.35% |
| 01:21PM | Lifshitz & Miller LLP Announces Investigation of Acacia Communications, Inc., AngioDynamics, Inc., ClubCorp Holdings, Inc., HD Supply Holdings, Inc., Ocular Therapeutix, Inc., Repros Therapeutics Inc. and Tahoe Resources Inc. PR Newswire |
| Jul-21-17 05:00PM | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AngioDynamics, Inc. - ANGO Accesswire |
| Jul-19-17 09:08AM | AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : July 19, 2017 Capital Cube |
| 09:08AM | AngioDynamics (ANGO) Shares Down Despite Q4 Earnings Beat Zacks |
| Jul-18-17 06:23PM | IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of AngioDynamics, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire -6.78% |
| 06:21PM | ANGIODYNAMICS (ANGO) INVESTOR ALERT: Legal Investigation for Potential Securities Law Violations Business Wire |
| 05:43PM | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of AngioDynamics, Inc. Business Wire |
| 04:49PM | AngioDynamics reports 4Q loss Associated Press |
| 03:28PM | IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire |
| 02:32PM | ANGIODYNAMICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In AngioDynamics, Inc. To Contact The Firm PR Newswire |
| 02:11PM | SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AngioDynamics, Inc. (ANGO) PR Newswire |
| 01:05PM | SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire |
| 12:00PM | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AngioDynamics, Inc. - ANGO PR Newswire |
| 06:00AM | AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results GlobeNewswire |
| Jul-07-17 06:00AM | AngioDynamics to Report Fiscal 2017 Fourth Quarter and Full-Year Financial Results GlobeNewswire |
| Jun-15-17 04:06PM | AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : June 15, 2017 Capital Cube |
| 01:03PM | ETFs with exposure to AngioDynamics, Inc. : June 15, 2017 Capital Cube |
| Jun-14-17 08:20AM | AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : June 14, 2017 Capital Cube |
| Jun-09-17 08:15AM | Featured Company News - Medical Devices Company AngioDynamics Receives FDA Clearance for Solero MTA System Accesswire |
| Jun-07-17 06:00AM | AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System GlobeNewswire |
| May-31-17 03:48PM | Albany public company files lawsuit alleging competitor violated antitrust laws American City Business Journals |
| 06:00AM | AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access GlobeNewswire |
| May-09-17 06:00AM | AngioDynamics to Present at the 2017 UBS Global Healthcare Conference GlobeNewswire |
| May-01-17 03:11AM | AngioDynamics (ANGO) Down 11.7% Since Earnings Report: Can It Rebound? Zacks |
| Apr-20-17 06:00AM | AngioDynamics to Present at the 41st Annual Deutsche Bank Health Care Conference GlobeNewswire |
| Apr-10-17 10:06AM | AngioDynamics (ANGO) Prices 2.5M Secondary Share Offering Zacks |
| 08:32AM | AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : April 10, 2017 Capital Cube |
| Apr-07-17 09:25AM | Endo international, AngioDynamics Lead Biotech Movers TheStreet.com |
| Apr-06-17 07:49PM | AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders GlobeNewswire |
| 04:02PM | AngioDynamics Announces Secondary Offering of 2.35 Million Shares of Common Stock by Selling Stockholders GlobeNewswire |
| Apr-05-17 04:18PM | ETFs with exposure to AngioDynamics, Inc. : April 5, 2017 Capital Cube |
| Apr-04-17 05:54PM | 5 Cheap Value Stocks to Tame a Capricious Market in Q2 Zacks |
| 09:23AM | AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q3, 2017 By the Numbers : April 4, 2017 Capital Cube |
| Apr-03-17 10:57AM | ANGIODYNAMICS INC Files SEC form 10-Q, Quarterly Report |
| Mar-31-17 11:04AM | AngioDynamics (ANGO) Beats on Q3 Earnings, Raises 2017 View Zacks |
| Mar-30-17 07:32PM | Edited Transcript of ANGO earnings conference call or presentation 30-Mar-17 12:00pm GMT Thomson Reuters StreetEvents |
| 01:35PM | AngioDynamics downgraded by KeyBanc Capital Mkts |
| 08:02AM | ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit |
|
|
|
|
| AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. In addition, the company provides thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. Further, it offers peripherally inserted central catheters; ports that are implantable devices for the central venous administration; and dialysis products. Additionally, the company provides microwave ablation products; radiofrequency ablation products for ablating solid cancerous or benign tumors; and NanoKnife ablation systems for the surgical ablation of soft tissues. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| DONNELLY HOWARD W | Director | Nov 21 | Option Exercise | 13.53 | 14,000 | 189,420 | 69,576 | Nov 22 01:48 PM | | Richard Stark | SVP, GM - Oncology | Nov 15 | Option Exercise | 11.45 | 27,409 | 313,815 | 48,163 | Nov 17 04:08 PM | | Richard Stark | SVP, GM - Oncology | Nov 15 | Sale | 16.29 | 27,409 | 446,493 | 20,754 | Nov 17 04:08 PM | | Gould Kevin J | Director | Sep 12 | Option Exercise | 14.03 | 39,000 | 547,170 | 65,064 | Sep 14 03:24 PM | | JOHNSON WESLEY | Director | Jul 25 | Option Exercise | 15.75 | 14,000 | 220,500 | 60,974 | Aug 08 05:48 PM | | Meteny Dennis S | Director | Jul 25 | Option Exercise | 15.75 | 14,000 | 220,500 | 83,127 | Aug 08 05:44 PM | | GOLD JEFFREY | Director | Jul 25 | Option Exercise | 15.75 | 14,000 | 220,500 | 66,037 | Jul 28 03:47 PM | | REED JAN STERN | Director | Jul 24 | Buy | 16.00 | 316 | 5,056 | 316 | Jul 25 02:33 PM | | DONNELLY HOWARD W | Director | Jul 21 | Buy | 15.72 | 5,000 | 78,600 | 47,600 | Jul 21 09:46 PM | | Clemmer James C | President and CEO | Jul 21 | Buy | 15.79 | 5,000 | 78,950 | 91,683 | Jul 21 06:43 PM | | Clemmer James C | President and CEO | Jul 20 | Buy | 15.64 | 20,000 | 312,800 | 86,683 | Jul 21 06:43 PM | | DONNELLY HOWARD W | Director | Jun 19 | Option Exercise | 15.75 | 14,000 | 220,500 | 56,144 | Jun 21 09:42 PM |
|
|
|
|
|
|
